Cytomegalovirus Disappearance After Treatment for Refractory Ulcerative Colitis in 2 Patients Treated with Infliximab and 1 Patient with Leukapheresis

被引：17

作者：

Criscuoli, Valeria ^{[1
]}

Mocciaro, Filippo ^{[1
]}

Orlando, Ambrogio ^{[1
]}

Rizzuto, Maria Rosa ^{[2
]}

Renda, Maria Concetta ^{[3
]}

Cottone, Mario ^{[1
]}

机构：

[1] V Cervello Hosp, Pneumol & Nutr Clin, Dept Gen Med, Palermo, Italy

[2] V Cervello Hosp, Inst Pathol, Palermo, Italy

[3] V Cervello Hosp, Hematol Div 2, Palermo, Italy

来源：

INFLAMMATORY BOWEL DISEASES | 2009年 / 15卷 / 06期

关键词：

TUMOR-NECROSIS-FACTOR; REACTIVATION; INFECTION; DISEASE;

D O I：

10.1002/ibd.20742

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：810 / 811

页数：2

共 9 条

[1] CYTOMEGALOVIRUS REACTIVATION AND TUMOR-NECROSIS-FACTOR [J].

DOCKE, WD ;

PROSCH, S ;

FIETZE, E ;

KIMEL, V ;

ZUCKERMANN, H ;

KLUG, C ;

SYRBE, U ;

KRUGER, DH ;

VONBAEHR, R ;

VOLK, HD .

LANCET, 1994, 343 (8892) :268-269

[2] The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration methods [J].

Dumont, LJ ;

Luka, J ;

VandenBroeke, T ;

Whitley, P ;

Ambruso, DR ;

Elfath, MD .

BLOOD, 2001, 97 (11) :3640-3647

[3]

FIETZE E, 1994, TRANSPLANTATION, V58, P675

[4] Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy [J].

Helbling, D ;

Breitbach, TH ;

Krause, M .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (12) :1393-1395

[5] CYTOMEGALOVIRUS AS AN EXACERBATING FACTOR IN ULCERATIVE-COLITIS [J].

LOFTUS, EV ;

ALEXANDER, GL ;

CARPENTER, HA .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 1994, 19 (04) :306-309

[6]

Papadakis KA, 2001, AM J GASTROENTEROL, V96, P2137, DOI 10.1111/j.1572-0241.2001.03949.x

[7]

Pfau P, 2001, AM J GASTROENTEROL, V96, P895, DOI 10.1111/j.1572-0241.2001.03672.x

[8] Latency and reactivation of human cytomegalovirus [J].

Sissons, JGP ;

Bain, M ;

Wills, MR ;

Sinclair, JH .

JOURNAL OF INFECTION, 2002, 44 (02) :73-77

[9]

Vancikova Z., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P179

← 1 →